I notice much arguement between biotech investors.May I make the point that there is only a limited amount of money is available for all these valuable research projects.This means that your favourite share may not spend as much time in the spotlight as you would like.However this does not mean that your company is wasting its time on research,only that commercial pressures will only allow a few through to be the final winners.
